Cognitive Testing

Cognitive testing in the context of Alzheimer's Disease and dementia is crucial for early detection and monitoring of cognitive decline. These tests assess various cognitive functions such as memory, attention, language abilities, and problem-solving skills. They help clinicians establish a baseline of cognitive function, track changes over time, and differentiate between normal aging and pathological conditions like Alzheimer's.

Commonly used tests include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Clock Drawing Test. These assessments provide valuable insights into a person's cognitive abilities and help in formulating personalized care plans. Early identification through cognitive testing allows for timely interventions, potentially slowing down cognitive decline and improving quality of life. Regular monitoring with these tests is essential for adapting care strategies as the disease progresses.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Facebook
Watsapp